Senl-h19 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Clinical trial NCT04792593 · UNKNOWN
Trial details
- NCT number
- NCT04792593
- Sponsor
- Hebei Senlang Biotechnology Inc., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-03
- Primary completion
- 2021-12-10
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.